Search research articles
Contact Us
Filters
Showing results (241-250 of 296) with videos related to
Page
of 30
Sort By:
Plos One
|
November 9, 2013
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development
Johnny C Akers, Valya Ramakrishnan, Ryan Kim, et al.
Neurosurgical Focus
|
October 4, 2016
Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience
Mir Amaan Ali, Kate T Carroll, Robert C Rennert, et al.
Journal of Neuro-Oncology
|
August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
J Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Journal of Neuro-Oncology
|
January 10, 2022
Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience
Isabela Peña Pino, Jun Ma, Yusuke S Hori, et al.
World Neurosurgery
|
July 24, 2017
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions
Mir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Plos One
|
June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy
Masayuki Nitta, David Kozono, Richard Kennedy, et al.
Journal of Neuro-Oncology
|
June 20, 2014
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study
Brian J Scott, Vincent A van Vugt, Toni Rush, et al.
Science Advances
|
December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival
Michael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
World Neurosurgery
|
July 30, 2017
Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume
Mir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2016
Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
Juliya Kalinina, Jun Ahn, Narra S Devi, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 296) with videos related to
Sort By:
Page
of 30
Plos One
|
November 9, 2013
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development
Johnny C Akers, Valya Ramakrishnan, Ryan Kim, et al.
Neurosurgical Focus
|
October 4, 2016
Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience
Mir Amaan Ali, Kate T Carroll, Robert C Rennert, et al.
Journal of Neuro-Oncology
|
August 10, 2012
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy
J Dawn Waters, Carlos Sanchez, Ayguen Sahin, et al.
Journal of Neuro-Oncology
|
January 10, 2022
Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience
Isabela Peña Pino, Jun Ma, Yusuke S Hori, et al.
World Neurosurgery
|
July 24, 2017
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions
Mir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Plos One
|
June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy
Masayuki Nitta, David Kozono, Richard Kennedy, et al.
Journal of Neuro-Oncology
|
June 20, 2014
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study
Brian J Scott, Vincent A van Vugt, Toni Rush, et al.
Science Advances
|
December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival
Michael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
World Neurosurgery
|
July 30, 2017
Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume
Mir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2016
Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase
Juliya Kalinina, Jun Ahn, Narra S Devi, et al.
Page
of 30